Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Katherine Fuh has not added Biography.
If you are Katherine Fuh and would like to personalize this page please email our Author Liaison for assistance.
Summary of the 2016 American Association for Cancer Research (AACR) Annual Meeting.
Gynecologic oncology Jul, 2016 | Pubmed ID: 27181388
AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer.
Oncotarget Nov, 2016 | Pubmed ID: 27764792
[Not Available].
Gynecologic oncology reports Feb, 2019 | Pubmed ID: 30582746
Proteogenomic Characterization of Endometrial Carcinoma.
Cell Feb, 2020 | Pubmed ID: 32059776
FIGO 2018 staging criteria for cervical cancer: Impact on stage migration and survival.
Gynecologic oncology Jun, 2020 | Pubmed ID: 32248993
Obese endometrial cancer survivors' perceptions of weight loss strategies and characteristics that may influence participation in behavioral interventions.
Gynecologic oncology reports May, 2021 | Pubmed ID: 33665293
Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer.
Gynecologic oncology Jul, 2021 | Pubmed ID: 33867143
Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment.
Nature communications Aug, 2021 | Pubmed ID: 34429404
Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment.
Nature communications Jan, 2022 | Pubmed ID: 34996889
Ridiculously good writing: How to write like a pro and publish like a boss.
Gynecologic oncology reports Aug, 2022 | Pubmed ID: 35719321
Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer.
Molecular cancer therapeutics Feb, 2019 | Pubmed ID: 30478151
p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts.
Scientific reports Mar, 2019 | Pubmed ID: 30886159
Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.
Gynecologic oncology Aug, 2019 | Pubmed ID: 31229298
Homologous recombination deficiency real-time clinical assays, ready or not?
Gynecologic oncology Dec, 2020 | Pubmed ID: 32967790
Phase 1b study of AVB-500 in combination with paclitaxel or pegylated liposomal doxorubicin platinum-resistant recurrent ovarian cancer.
Gynecologic oncology Nov, 2021 | Pubmed ID: 34474927
GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress.
Molecular cancer research : MCR Feb, 2022 | Pubmed ID: 34670865
Culturing Primary Human Mesothelial Cells.
Methods in molecular biology (Clifton, N.J.) , 2022 | Pubmed ID: 34918292
Washington University in St. Louis
University of California San Francisco
Lillian van Biljon1,
Bisiayo Fashemi1,
Jeimmy Rodriguez1,
Olivia Graham1,
Amanda Compadre1,
Katherine Fuh1,2,
Dineo Khabele1,
Mary Mullen1
1, Washington University in St. Louis,
2, University of California San Francisco
Olivia Graham*,1,
Jeimmy Rodriguez*,1,
Emily Graham1,
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.